GOMA MAYBERRY: Open Payments
NPI 1588101174 · ORMOND BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$555 in 19 payments from 7 companies in 2025. Trend: 2023 $670 · 2024 $455 · 2025 $555
Food & beverage: $555
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $339 |
| GlaxoSmithKline, LLC. | 5 | $75 |
| Novo Nordisk Inc | 2 | $47 |
| Exact Sciences Corporation | 1 | $28 |
| Medtronic, Inc. | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| PFIZER INC. | 1 | $17 |
Products named: BREZTRI, TRELEGY ELLIPTA, AIRSUPRA, Ozempic, The Cologuard Plus Collection Kit, MINIMED 780G, XIFAXAN, ELIQUIS.
Industry payments across FL — which companies pay providers there.
